Background: Traditional Post-Intensive Care Recovery Clinics (PIRCs) often exclude neurocritical care patients. In 2020, a multidisciplinary team started Post Neuro Intensive Care Virtual Clinic (PREVAIL) that uses telemedicine to provide consultative care for patients with a primary neurologic injury who are at risk for post-intensive care syndrome. During clinic, critical care pharmacists perform medication reconciliations and provide drug therapy recommendations. Objectives: The objective of this observational review is to describe the pharmacists’ interventions and role in a novel PIRC. Methods: A retrospective, observational review was conducted for patients who were seen in PREVAIL from December 2020 to January 2022. The pharmacist completed a medication reconciliation and provided drug therapy recommendations. Results: Amongst fifty-two PREVAIL patients, the most common neurologic diagnosis was intracerebral hemorrhage, seizures, and acute ischemic stroke. All patients were mechanically ventilated during their ICU stay, with a median ICU length of stay of 17 days [IQR 10-26]. After medication reconciliation, 93% of patients required adjustments to their medication list. After patient examination, 89% of patients required a drug therapy recommendation, with a median of three interventions per patient. Various medication classes were intervened on, most frequently antipsychotics, anti-seizure medications, antihypertensives, anticoagulants, neuromodulators, and antidepressants. Conclusion: This is the first study to evaluate pharmacist contributions at a consultative telemedicine PIRC that focuses on providing care for patients with a primary neurologic injury. PREVAIL pharmacists have a crucial role in the multidisciplinary team. Future research is required to determine the pharmacist’s impact on clinical outcomes.
ZimmermanJEKramerAAKnausWA. Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care. 2013;17(2):R81.
2.
NeedhamDMDavidsonJCohenH, et al.Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med. 2012;40(2):502-509.
3.
ElliottDDavidsonJEHarveyMA, et al.Exploring the scope of post-intensive care syndrome therapy and care: engagement of non-critical care providers and survivors in a second stakeholders meeting. Crit Care Med. 2014;42(12):2518-2526.
4.
YanagiNKamiyaKHamazakiN, et al.Post-intensive care syndrome as a predictor of mortality in patients with critical illness: a cohort study. PLoS One. 2021;16(3):e0244564.
5.
MikkelsenMEChristieJDLankenPN, et al.The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med. 2012;185(12):1307-1315.
6.
PandharipandePPGirardTDJacksonJC, et al.Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306-1316.
7.
TullyAPHammondDALiCJarrellASKruerRM. Evaluation of medication errors at the transition of care from an ICU to non-ICU Location. Crit Care Med. 2019;47(4):543-549.
8.
SevinCMJacksonJC. Post-ICU clinics should be staffed by ICU clinicians. Crit Care Med. 2019;47(2):268-272.
9.
StollingsJLBloomSLWangLElyEWJacksonJCSevinCM. Critical care pharmacists and medication management in an ICU recovery center. Ann Pharmacother. 2018;52(8):713-723.
10.
MohammadRAEzeCMarshallVD, et al.The impact of a clinical pharmacist in an interprofessional intensive care unit recovery clinic providing care to intensive care unit survivors. J Am Coll Clin Pharm. 2022;5(10):1027-1038.
11.
AdieSKThompsonANKonermanMCSheaMJThomasMPThompsonAD. Impact of a pharmacist in an interdisciplinary post-cardiac intensive care unit clinic. Heart Lung. 2022;52:48-51.
12.
LaBuzettaJNRosandJVranceanuAM. Review: post-intensive care syndrome: unique challenges in the neurointensive care unit. Neurocrit Care. 2019;31(3):534-545.
13.
MullenMTAndersonCS. Review of long-term blood pressure control after intracerebral hemorrhage: challenges and opportunities. Stroke. 2022;53(7):2142-2151.
14.
PhamHTTranMHNguyenNQTan VoVTranMH. Role of clinical pharmacists in epilepsy management at a general hospital in Vietnam: a before-and-after study. J of Pharm Policy and Pract. 2021;14:109-2021.
15.
YukawaE. Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring. Clin Pharmacokinet. 1996;31(2):120-130.
16.
Kane-GillSLWongACulleyCM, et al.Transforming the medication regimen review process using telemedicine to prevent adverse events. J Am Geriatr Soc. 2021;69(2):530-538.
17.
JalilianLCannessonMKamdarN. Post-ICU recovery clinics in the era of digital health and telehealth. Crit Care Med. 2019;47(9):e796-e797.
